Skip to content
The Policy VaultThe Policy Vault

Revlimid (lenalidomide capsules) — Cigna

Mantle Cell Lymphoma

Initial criteria

  • Patient age ≥ 18 years
  • The medication is used in combination with rituximab OR Patient has tried at least one other regimen

Approval duration

1 year